Shree Ganesh Bio-Tech Stock Screener | Share Price & Fundamental Analysis
SHREEGANES
Biotechnology
Screen Shree Ganesh Bio-Tech share price with our stock screener - analyze fundamentals and track trades in your journal
Share Price BSE
₹0.67
▼
-0.02 (-2.90%)
Market Cap
₹27.50 Cr.
P/B Ratio
0.43
EPS (TTM)
₹0.01
Dividend Yield
-
Debt to Equity
-
52W High
₹1.12
52W Low
₹0.60
Operating Margin
-25.00%
Profit Margin
-
Revenue (TTM)
₹21.00
EBITDA
-
Net Income
-
Total Assets
₹64.00
Total Equity
₹63.00
Shree Ganesh Bio-Tech Share Price History - Stock Screener Chart
Screen SHREEGANES historical share price movements with interactive charts. Analyze price trends and patterns.
Shree Ganesh Bio-Tech Company Profile - Fundamental Screener
Screen Shree Ganesh Bio-Tech company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for SHREEGANES shares.
Sector
Healthcare
Industry
Biotechnology
Sub-Sector
Biotechnology
Segment
E
ISIN
INE051N01026
Shree Ganesh Bio-Tech Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen SHREEGANES balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 64 | 74 | 80 | 94 | 75 | 65 | 64 | 26 | 19 | 5 |
| Current Assets | 3 | 4 | 20 | 44 | 28 | 21 | 19 | 14 | 9 | 3 |
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 |
| Liabilities | ||||||||||
| Total Liabilities | 64 | 74 | 80 | 94 | 75 | 65 | 64 | 26 | 19 | 5 |
| Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 63 | 63 | 62 | 60 | 58 | 58 | 57 | 23 | 19 | 5 |
| Share Capital | 40 | 40 | 40 | 20 | 20 | 20 | 20 | 2 | 2 | 2 |
| Reserves & Surplus | 23 | 23 | 23 | 40 | 38 | 38 | 37 | 10 | 7 | 3 |
Screen SHREEGANES income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | None-None | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March | 2015-March |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 21 | 24 | 21 | 63 | 73 | 17 | 3 | 6 | 8 | 9 | 2 | 2 |
| Expenses | 21 | 24 | 21 | 60 | 69 | 17 | 2 | 4 | 4 | 5 | 2 | 1 |
| EBITDA | 0 | 0 | 1 | 3 | 4 | 1 | 0 | 2 | 4 | 4 | 1 | 1 |
| Operating Profit % | -25.00% | -5.00% | -1.00% | 3.00% | 5.00% | 4.00% | 10.00% | 31.00% | 45.00% | 44.00% | 31.00% | 30.00% |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 0 | 0 | 1 | 3 | 4 | 0 | 0 | 2 | 4 | 4 | 1 | 0 |
| Tax | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 0 | 0 | 1 | 2 | 3 | 0 | 0 | 2 | 4 | 4 | 1 | 0 |
| EPS | 0.00 | 0.01 | 0.02 | 0.05 | 0.13 | 0.16 | 0.12 | 0.90 | 19.12 | 20.39 | 2.94 | 1.88 |
Shree Ganesh Bio-Tech Cash Flow Screener - Liquidity Fundamentals
Screen SHREEGANES cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | -10 | 10 | 11 | 4 | 2 | -1 | -1 | 2 | -13 | 0 |
| Investing Activities | 10 | -10 | -10 | -3 | -2 | 1 | -32 | -2 | 3 | 0 |
| Financing Activities | 0 | 0 | 0 | 0 | 0 | 0 | 33 | 0 | 10 | 0 |
| Net Cash Flow | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Screen SHREEGANES shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| FII Holding | 1.42% | 1.42% | 1.42% | 1.42% | 1.42% | 1.42% | 1.42% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 95.24% | 95.30% | 95.27% | 94.65% | 95.39% | 95.31% | 95.29% | 65.65% |
| Other Holding | 3.34% | 3.28% | 3.31% | 3.93% | 3.19% | 3.27% | 3.29% | 34.35% |
| Shareholder Count | 195,435 | 192,235 | 189,375 | 176,722 | 181,198 | 185,335 | 192,040 | 69,895 |
Shree Ganesh Bio-Tech Dividend Screener - Share Yield Analysis
Screen SHREEGANES dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
Shree Ganesh Bio-Tech Index Membership - Market Screener Classification
Screen SHREEGANES by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Shree Ganesh Bio-Tech Market Events Screener - Corporate Actions
Screen SHREEGANES market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | -4.46% | ||
| Annual General Meeting | NA | -1.28% | ||
| 2025-11-08 | 2025-11-08 | Quarterly Result Announcement | NA | -1.35% |
| 2025-07-25 | 2025-07-25 | Quarterly Result Announcement | NA | -2.41% |
| 2025-05-22 | 2025-05-22 | Quarterly Result Announcement | NA | 5.88% |
| 2025-02-04 | 2025-02-04 | Quarterly Result Announcement | NA | -4.04% |
| 2024-10-23 | 2024-10-23 | Quarterly Result Announcement | NA | -4.59% |
| 2022-04-27 | 2022-04-28 | Bonus | 1:1 | -26.76% |
Shree Ganesh Bio-Tech Competitors Screener - Peer Comparison
Screen SHREEGANES competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Anthem Biosciences | 36,224 | 71.34 | 1,930 | 30.15% | 451 | 44.48 |
| Advanced Enzyme Tech | 3,372 | 23.19 | 670 | 1.44% | 134 | 45.49 |
| Genesis IBRC | 119 | -484.83 | 4 | % | 0 | 42.21 |
| Vivo Bio Tech | 69 | 17.45 | 52 | 13.19% | 7 | 50.67 |
| Shree Ganesh Bio-Tech | 28 | 24 | 14.55% | 0 | 64.94 | |
| Genomic Valley Biotech | 8 | 76.24 | 1 | 300.00% | 0 | 52.18 |
Shree Ganesh Bio-Tech Company Announcements - News Screener
Screen SHREEGANES latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-01-06 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-12-20 | Closure of Trading Window | View |
| 2025-11-08 | Disclosure Under Regulation 32(1) Of SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015 | View |
| 2025-11-08 | Regulations 30 33 And Other Applicable Provisions Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 | View |
| 2025-11-08 | Board Meeting Outcome for Outcome Of The Board Meeting Of The Board Held On 8Th November 2025. | View |
| 2025-10-30 | Board Meeting Intimation for Compliance Of Regulation 29 Of SEBI (LODR) Regulations 2015 - Intimation Of Board Meeting | View |
| 2025-10-08 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-09-27 | Closure of Trading Window | View |
| 2025-09-26 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | View |
| 2025-09-26 | Shareholder Meeting / Postal Ballot-Outcome of AGM | View |
| 2025-09-06 | Updation In The Website Of The Company. | View |
| 2025-08-25 | Reg. 34 (1) Annual Report. | View |
| 2025-08-25 | Intimation Of Book Closure Pursuant To Regulation 42 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015. | View |
| 2025-08-25 | Submission Of Notice Of Annual General Meeting Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 | View |
| 2025-07-25 | Disclosure Under Regulation 32(1) Of SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015 | View |
| 2025-07-25 | Regulations 30 33 And Other Applicable Provisions Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 | View |
| 2025-07-25 | Board Meeting Outcome for Outcome Of The Board Meeting Of The Board Held On 25Th July 2025. | View |
| 2025-07-16 | Board Meeting Intimation for Compliance Of Regulation 29 Of SEBI (LODR) Regulations 2015 - Intimation Of Board Meeting. | View |
| 2025-07-04 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-06-26 | Closure of Trading Window | View |